C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
07/2000
07/19/2000	CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same
07/18/2000	US6090941 Pharmaceutically active benzoquinazoline compounds
07/18/2000	US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
07/12/2000	EP1017693A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
07/12/2000	EP1017384A1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
07/12/2000	EP0592435B1 Process for the preparation of pyrimidine compounds
07/12/2000	CN1259346A Optically pure compound as medicinal use
07/11/2000	CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
07/06/2000	WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors
07/06/2000	WO2000039125A1 Piperidines as ccr5 modulators
07/06/2000	WO2000039124A1 Thrombin inhibitors
07/06/2000	WO2000039098A1 Synthesis of histamine dihydrochloride
07/06/2000	WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands
07/06/2000	WO2000038725A1 Combinations for cardiovascular indications
07/06/2000	WO2000038680A1 Azabicycloalkanes as ccr5 modulators
07/06/2000	CA2356515A1 Combinations for cardiovascular indications
07/06/2000	CA2355281A1 Thrombin inhibitors
07/05/2000	EP1015451A1 Tetrahydro gamma-carbolines
07/05/2000	EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
07/04/2000	US6084103 Forming a carbamate from methyl 4-nitro-(l)-phenylalaninate hydrochloride; reducing the nitro and ester groups; ring closure free of phosgene; forming a diazonium salt without using tin chloride; fischer reaction; migraines; 5ht1-agonist
07/04/2000	US6083880 Saccharine-5-carbonyl-cyclohexane-1, 3, 5-trione derivatives, their preparation and their use as herbicides
06/2000
06/29/2000	WO2000037141A1 Combination chemotherapy
06/29/2000	CA2352326A1 Combination chemotherapy
06/28/2000	EP1013647A2 Process for the preparation of N-(amino-4,6-dihalogenopyrimidin)-formamides
06/28/2000	EP1012140A1 New amidino derivatives and their use as thrombin inhibitors
06/28/2000	EP1011664A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000	CN1258295A Novel form of S-omeprazole
06/28/2000	CN1053905C Oxadiazine derivs., their preparing process and use, intermediates for preparing same
06/27/2000	US6080875 Method for preparing 2-thienylethylamine derivatives
06/27/2000	US6080869 Chemical reduction process; forming dopamine da2 receptor agonists and beta2 adrenoreceptor agonists for treating obstructive airways diseases
06/22/2000	WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors
06/21/2000	CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000	CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers
06/20/2000	US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/15/2000	WO2000034283A1 Novel triazolo(4,5-d)pyrimidine compounds
06/15/2000	WO2000034263A1 Benzofuran derivatives, their preparation and use
06/15/2000	WO2000033878A2 Stabilization of macrolides
06/15/2000	CA2732620A1 Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000	CA2651609A1 Crystalline form of 40-o- (2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000	CA2353618A1 Benzofuran derivatives, their preparation and use
06/15/2000	CA2351390A1 Thiourea inhibitors of herpes viruses
06/14/2000	EP0525057B1 Antimicrobial quinolonyl lactams
06/13/2000	US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/08/2000	WO2000032589A1 Eletriptan hydrobromide monohydrate
06/08/2000	WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/07/2000	EP1006110A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
06/07/2000	CN1255497A Method for preparing pyrazo [4,3-d] pyrimidine-7-one and its intermediate
06/07/2000	CN1255496A Application of heterobicyclic alcohol antimer for preparing piperazine derivative
06/06/2000	US6071916 Sulfate salts having improved solubility in gastric acid solution resulting in greater oral absorption/bioavailability aids; arc(aids-related complex); containing benzofuran, piperazine, benzene and indane rings
06/02/2000	WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000	CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
05/2000
05/31/2000	EP1003728A1 2- 3- 4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto pyrimidin-4-ol-fumarate
05/31/2000	EP1003725A1 Fluoropyrazole-biphenylamide fungicides
05/30/2000	CA2004747C Substituted phenylpyrimidines useful in the treatment of cns disorders
05/25/2000	WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
05/24/2000	EP1002795A1 HIV Replication inhibiting pyrimidines
05/24/2000	EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES
05/24/2000	EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES
05/24/2000	EP1001686A1 Dehydration plant
05/24/2000	CN1254328A Process for preparing substituted 2-3-dihydro-1-indanones
05/18/2000	WO2000027825A1 Hiv replication inhibiting pyrimidines
05/18/2000	WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/18/2000	CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
05/17/2000	EP1000038A1 Novel pyrimidin derivatives
05/17/2000	EP1000035A1 Substituted 6-phenylphenanthridines
05/17/2000	EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000	EP1000027A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
05/17/2000	EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
05/17/2000	EP0999830A1 Sertraline salts and sustained-release dosage forms of sertraline
05/17/2000	CN1253557A Vitamin D3 analogs with bis C-20 side chains
05/17/2000	CN1253551A Pyrazine compounds
05/16/2000	US6063932 Arthropodicides
05/16/2000	US6063789 Antiinflammatory agents
05/16/2000	US6063787 Methods for the treatment of psoriasis and genital warts
05/16/2000	CA2129288C Phosphonooxymethyl esters of taxane derivatives
05/16/2000	CA2013226C Cephalosporin derivatives and processes for their preparation
05/10/2000	EP0998464A1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
05/10/2000	CN1052229C 7-deoxy taxols and its medicinal composition
05/04/2000	WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000	CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/03/2000	EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000	EP0996622A1 Novel spiroazabicyclic heterocyclic compounds
05/03/2000	EP0743940B1 New compounds with analgesic and local anaesthetic effect
05/03/2000	CN1252065A Process for preparing substituted thiazolidinedione
05/03/2000	CN1252000A Pharmaceutical compositions having appetite suppressant activity
05/03/2000	CN1251836A Preparation of intermediate for monocyclic beta-lactams derivatives
05/03/2000	CN1051990C Method for preparing ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
05/02/2000	US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/02/2000	US6057349 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxphenyl, and aminophenyl alkylsulfonamides and ureas and their use
04/2000
04/27/2000	WO2000023434A1 Improved phlegmatization of cyclic ketone peroxides
04/27/2000	WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000	WO2000023423A1 Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes
04/27/2000	DE19848521A1 Preparation of (+)-exo-6-phenyl-3-azabicyclo(3.2.0)heptane derivatives comprises photocyclization of bisallyl ammonium salts, isomer resolution using (-)-ditoluoyltartaric acid and crystallization
04/27/2000	CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000	CA2347077A1 Improved phlegmatization of cyclic ketone peroxides
04/26/2000	EP0995755A1 Prodrugs of Thrombin inhibitors
04/26/2000	EP0995742A1 Sulfonamide compounds and medicinal use thereof
04/26/2000	EP0994880A1 Crystalline macrolides and process for their preparation
04/26/2000	EP0994872A1 4-phenylpiperidine compounds
04/26/2000	EP0777671B1 Spiro-azabicyclic compounds useful in therapy

1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 105